With reference to its letter No. JPL/CS/1899/2023 dated 7th February, 2023, Jenburkt Pharmaceuticals has informed that it enclosed, clippings of two Newspapers, The Free Press Journal, Mumbai (English) and Navshakti, Mumbai (Marathi) dated 8th February, 2023 containing the standalone Unaudited Financial Results of the Company for the quarter and nine months ended on 31st December, 2022.
The above information is a part of company’s filings submitted to BSE.